Genomic Vision Société Anonyme G09.F Stock
Genomic Vision Société Anonyme Price Chart
Genomic Vision Société Anonyme G09.F Financial and Trading Overview
Genomic Vision Société Anonyme stock price | 0.0017 EUR |
Previous Close | 0.0093 EUR |
Open | 0.0093 EUR |
Bid | 0.0093 EUR x 52900 |
Ask | 0.02 EUR x 51900 |
Day's Range | 0.0093 - 0.0093 EUR |
52 Week Range | 0.0047 - 0.14 EUR |
Volume | 80K EUR |
Avg. Volume | 2.81K EUR |
Market Cap | 3.88M EUR |
Beta (5Y Monthly) | -0.574329 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
G09.F Valuation Measures
Enterprise Value | N/A |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.6195605 |
Price/Book (mrq) | 1.0333334 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
Genomic Vision Société Anonyme Stock Price History
Beta (5Y Monthly) | -0.574329 |
52-Week Change | -83.76% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.14 EUR |
52 Week Low | 0.0047 EUR |
50-Day Moving Average | 0.02 EUR |
200-Day Moving Average | 0.04 EUR |
G09.F Share Statistics
Avg. Volume (3 month) | 2.81K EUR |
Avg. Daily Volume (10-Days) | 8K EUR |
Shares Outstanding | 279.11M |
Float | N/A |
Short Ratio | N/A |
% Held by Insiders | 4.46% |
% Held by Institutions | 1.79% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -413.36% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | N/A |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 1.48M EUR |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | 3.79% |
Gross Profit (ttm) | -6056000 EUR |
EBITDA | -5907000 EUR |
Net Income Avi to Common (ttm) | -6790000 EUR |
Diluted EPS (ttm) | -0.06 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | N/A |
Total Cash Per Share (mrq) | N/A |
Total Debt (mrq) | N/A |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | N/A |
Book Value Per Share (mrq) | 0.009 |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of Genomic Vision Société Anonyme
Country | Germany |
State | N/A |
City | Bagneux |
Address | Green Square Batiment East |
ZIP | 92220 |
Phone | 33 1 49 08 07 40 |
Website | https://www.genomicvision.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 36 |
Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; and accessories, such as custom treated glass carriers and disposable DNA reservoirs for use with the MCS, as well as sample cartridges for scanners. It also provides FiberProbes for BRCA that is a set of Genomic Morse Codes for the detection of mutations occurring in hereditary breast and ovarian cancer; and hereditary nonpolyposis colorectal cancer Genomic Morse Code sets, which allows the identification and characterization of various structural variations, including anomalies occurring in flanking regions of the MMR genes. In addition, the company offers combing services that allow customers to validate the planned gene editing events; detect incorrect events larger than 1kb, including incorrect deletions, insertions, or inversions; and quantify off-target/on-target ratios. It has a strategic alliance with Quest Diagnostics; and development agreement with La Timone Hospital; research and development agreement with the Institut Pasteur. Genomic Vision Société Anonyme was founded in 2004 and is headquartered in Bagneux, France.
Q&A For Genomic Vision Société Anonyme Stock
What is a current G09.F stock price?
Genomic Vision Société Anonyme G09.F stock price today per share is 0.0017 EUR.
How to purchase Genomic Vision Société Anonyme stock?
You can buy G09.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Genomic Vision Société Anonyme?
The stock symbol or ticker of Genomic Vision Société Anonyme is G09.F.
Which industry does the Genomic Vision Société Anonyme company belong to?
The Genomic Vision Société Anonyme industry is Diagnostics & Research.
How many shares does Genomic Vision Société Anonyme have in circulation?
The max supply of Genomic Vision Société Anonyme shares is 407.76M.
What is Genomic Vision Société Anonyme Price to Earnings Ratio (PE Ratio)?
Genomic Vision Société Anonyme PE Ratio is 0.00000000 now.
What was Genomic Vision Société Anonyme earnings per share over the trailing 12 months (TTM)?
Genomic Vision Société Anonyme EPS is 0 EUR over the trailing 12 months.
Which sector does the Genomic Vision Société Anonyme company belong to?
The Genomic Vision Société Anonyme sector is Healthcare.